Table 2.
CRAE |
CRVE |
||||
---|---|---|---|---|---|
N at riska | rb | P | rb | P | |
Change in: | |||||
Glomerular filtration rate | 236 | −0.03 | 0.61 | 0.00 | 0.98 |
Albumin excretion rate | 234 | 0.00 | 0.96 | 0.01 | 0.93 |
Mesangial fractional volume/glomerulus | 234 | 0.08 | 0.20 | 0.07 | 0.28 |
Mesangial matrix fractional volume/glomerulus | 234 | 0.12 | 0.07 | 0.13 | 0.05 |
Mesangial cell fractional volume/glomerulus | 234 | −0.02 | 0.71 | −0.00 | 0.99 |
Glomerular basement membrane (GBM) width (nm) | 234 | 0.11 | 0.08 | 0.10 | 0.12 |
Peripheral GBM surface density/glomerulus | 234 | −0.11 | 0.09 | −0.16 | 0.02 |
Volume fraction of cortex which was interstitium | 183 | −0.03 | 0.64 | 0.08 | 0.26 |
Volume fraction cortical tubules per total tubules which were atrophic | 165 | −0.09 | 0.23 | −0.011 | 0.16 |
Glomerulopathy index | 234 | 0.14 | 0.03 | 0.13 | 0.04 |
Incident abnormal: | |||||
Mesangial fractional volume/glomerulus (n = 30) | 206 | −0.05 | 0.50 | −0.04 | 0.61 |
Mesangial matrix fractional volume/glomerulus (n = 43) | 165 | 0.11 | 0.14 | 0.12 | 0.13 |
Mesangial cell fractional volume/glomerulus (n = 20) | 216 | 0.02 | 0.74 | −0.00 | 0.95 |
GBM width (n = 27) | 93 | 0.09 | 0.41 | 0.10 | 0.35 |
Peripheral GBM surface density/glomerulus (n = 61) | 206 | 0.08 | 0.25 | 0.14 | 0.05 |
Glomerulopathy index (n = 27) | 86 | 0.23 | 0.04 | 0.22 | 0.04 |
Numbers at risk vary due to gradable measurement of nephropathy measures and those with prevalent abnormal values at baseline.
r = Pearson correlation for continuous measures (top 9 rows) and Spearman correlation for categorical measures (bottom 6 rows).